04/17/2026
Tattoo-associated Eye Disease: An emerging eye health challenge.
Tattoo ink inflammation has been found to increasingly trigger uveitis (a serious form of eye inflammation affecting the middle tissue layer of the eye, causing sudden redness, pain, and blurry vision), often harming vision and requiring systemic steroids.
Tattoo-associated uveitis was once considered rare; however, that appears to be no longer true, according to a new Australian report that describes it as an emerging eye health challenge, according to Ezann Siebert from the Royal Perth Hospital, Perth, Western Australia.
“Tattoo-associated uveitis is a potentially sight-threatening condition driven by a presumed immune reaction to tattoo ink. The case numbers may be rising as tattooing becomes more popular,” the investigators commented.
The ink used in tattoos can cause many inflammatory reactions in the body, and while the skin reportedly is the most common site, systemic inflammation also has been reported. The signs of skin inflammation include scattered papules, nodules, scaling, induration, pruritus, and tenderness at the tattoo site.2 Granulomatous reactions have been reported in association with allergic dermatitis, foreign body granuloma, melanoma, sarcoidosis, hematological malignancy, and metastatic solid organ cancers.3
In the eye, tattoo-associated uveitis results from an immune response triggered by tattoo pigment, especially that in black ink, according to the authors. Currently, about 39 cases have been reported. “Inflamed tattoos are most commonly associated with bilateral anterior uveitis, but posterior involvement, including optic disc swelling, cystoid macular edema, and retinal detachment, also has been reported.
In this multi-center retrospective case review, the investigators collaborated with uveitis specialists from January 2023 to January 2025.
“Inflammation within tattoos was present in all cases, most commonly associated with black ink. Systemic treatment was needed in 67.5%, of which many required steroid-sparing immunosuppression, most commonly methotrexate. In some cases, biologic disease-modifying anti-rheumatic drugs were required.
Other complications reported were cataracts, cystoid macular edema, and glaucoma. Only three patients had no visual loss during the treatment course. The documented visual acuities were worse than 20/30 in 15.4% of affected eyes, the authors reported.
Siebert and colleagues believe that the previously rare tattoo-associated uveitis “appears to be emerging as a public eye health issue,” considering that the numbers of individuals undergoing tattooing are rising.
Clin Exp Ophthalmol. 2026;54:33-43.
